$176 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 24 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 63.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | BIOHAVEN LTD | $59,289,000 | – | 392,200 | +100.0% | 33.68% | – | |
| QUIDELORTHO CORP | $35,687,000 | -26.4% | 499,263 | 0.0% | 20.27% | +37.5% | ||
| MRTX | Buy | MIRATI THERAPEUTICS INC | $21,345,000 | +81.7% | 305,629 | +74.6% | 12.12% | +239.7% |
| OPK | Sell | OPKO HEALTH INC | $9,644,000 | -47.4% | 5,102,756 | -29.6% | 5.48% | -1.7% |
| AGEN | Sell | AGENUS INC | $9,207,000 | +1.9% | 4,491,260 | -3.5% | 5.23% | +90.6% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $8,087,000 | +127.6% | 1,393,165 | +73.3% | 4.59% | +325.8% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $8,003,000 | +25.2% | 635,194 | +5.2% | 4.55% | +134.2% |
| Buy | SEMA4 HOLDINGS CORP | $7,374,000 | -11.1% | 8,403,926 | +27.6% | 4.19% | +66.2% | |
| FORA | Buy | FORIAN INC | $4,718,000 | -19.4% | 1,408,432 | +5.6% | 2.68% | +50.7% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $3,357,000 | +38.3% | 2,208,872 | -9.7% | 1.91% | +158.4% |
| IMMP | IMMUTEP LTDsponsored ads | $2,429,000 | -23.2% | 1,557,325 | 0.0% | 1.38% | +43.8% | |
| IBRX | New | IMMUNITYBIO INC | $1,567,000 | – | 315,322 | +100.0% | 0.89% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INCcall | $1,100,000 | +46.1% | 100,000 | +65.0% | 0.62% | +172.9% |
| TQQQ | Sell | PROSHARES TRultrapro qqq | $966,000 | -73.2% | 50,000 | -66.7% | 0.55% | -49.8% |
| Sell | DERMTECH INC | $699,000 | -48.8% | 176,569 | -28.4% | 0.40% | -4.3% | |
| BIIB | BIOGEN INC | $644,000 | +30.9% | 2,412 | 0.0% | 0.37% | +145.6% | |
| XBI | New | SPDR SER TRs&p biotech | $526,000 | – | 6,633 | +100.0% | 0.30% | – |
| CANO | New | CANO HEALTH INC | $295,000 | – | 34,049 | +100.0% | 0.17% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INCcall | $281,000 | -57.2% | 250,000 | -28.6% | 0.16% | -19.6% |
| AWH | ASPIRA WOMENS HEALTH INC | $271,000 | -36.7% | 728,100 | 0.0% | 0.15% | +18.5% | |
| Buy | VELO3D INC | $256,000 | +509.5% | 65,000 | +114.0% | 0.14% | +1015.4% | |
| IWM | New | ISHARES TRput | $146,000 | – | 150,000 | +100.0% | 0.08% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $144,000 | – | 100,000 | +100.0% | 0.08% | – |
| AGEN | New | AGENUS INCcall | $4,000 | – | 165,600 | +100.0% | 0.00% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -300,000 | -100.0% | -0.02% | – |
| VTNR | Exit | VERTEX ENERGY INCcall | $0 | – | -150,300 | -100.0% | -0.02% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -2,132,000 | -100.0% | -0.12% | – |
| VTNR | Exit | VERTEX ENERGY INC | $0 | – | -56,800 | -100.0% | -0.18% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -129,810 | -100.0% | -0.27% | – |
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -463,998 | -100.0% | -0.41% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -500,000 | -100.0% | -0.46% | – |
| CFRX | Exit | CONTRAFECT CORP | $0 | – | -1,969,222 | -100.0% | -1.84% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -89,700 | -100.0% | -3.89% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -1,240,932 | -100.0% | -54.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.